This page is part of the Da Vinci Risk Adjustment FHIR Implementation Guide (v1.0.0: STU 1) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Examples

• Bundle01: Risk Adjustment Bundle, (MeasureReport01: Patient01)

• Condition01Pat03: Other artificial openings of gastrointestinal tract status
• Condition02pat01: Diabetes mellitus due to underlying condition with other diabetic kidney complication
• Condition03pat01: Chronic obstructive pulmonary disease with (acute) exacerbation
• Condition04Pat03: Chronic obstructive pulmonary disease with (acute) exacerbation
• Condition05Pat03: Unspecified protein-calorie malnutrition
• Condition06Pat03: Crohn’s disease of large intestine with unspecified complications
• Condition07Pat03: Other persistent atrial fibrillation
• Condition08pat01: Bipolar disorder, current episode mixed, mild
• Condition09Pat01: Allergic bronchopulmonary aspergillosis
• Condition10Pat01: Long term (current) use of insulin
• Condition11Pat01: Acute pulmonary edema
• Condition15Pat03: Diabetes mellitus due to underlying condition with diabetic chronic kidney disease
• Condition16Pat03: Dependence on renal dialysis
• Condition17Pat01: Body mass index (BMI) 45.0-49.9, adult
• Condition18Pat01: Longstanding persistent atrial fibrillation
• Condition21Pat03: Type 2 diabetes mellitus without complications
• Condition22Pat03: Other acute kidney failure
• Condition23Pat03: Chronic kidney disease, stage 5
• Condition31Pat02: Typical atrial flutter
• Condition32Pat03: Chronic pulmonary embolism
• Condition33Pat01: Respiratory arrest
• Condition35Pat03: Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene
• Condition42Pat03: Other artificial openings of gastrointestinal tract status
• Condition43pat01: Diabetes mellitus due to underlying condition with other diabetic kidney complication

• Condition44Pat01: Allergic bronchopulmonary aspergillosis

• Encounter01Pat03: Pat03 Encounter on 2021-07-14
• Encounter02Pat01: Pat01 Encounter on 2021-01-31
• Encounter03Pat01: Pat01 Encounter on 2021-09-26
• Encounter04Pat03: Pat03 Encounter on 2020-12-18
• Encounter05Pat03: Pat03 Encounter on 2020-03-03
• encounter06Pat03: Pat03 Encounter on 2020-09-17
• Encounter07Pat03: Pat03 Encounter on 2019-02-07
• Encounter08Pat01: Pat01 Encounter on 2017-02-03
• Encounter09Pat01: Pat01 Encounter on 2021-03-27
• Encounter11Pat01: Pat01 Encounter on 2020-11-02
• Encounter15Pat03: Pat03 Encounter on 2021-08-08
• Encounter16Pat03: Pat03 Encounter on 2021-07-27
• Encounter19Pat03: Pat03 Encounter on 2019-08-23
• Encounter21Pat03: Pat03 Encounter on 2021-01-30
• Encounter22Pat03: Pat03 Encounter on 2021-07-01
• Encounter31Pat02: Pat02 Encounter on 2021-08-06
• Encounter35Pat03: Pat03 Encounter on 2021-02-12
• Encounter42Pat03: Pat03 Encounter on 2020-02-10
• Encounter43Pat01: Pat01 Encounter on 2019-02-10
• Encounter44Pat01: Pat01 Encounter on 2017-01-18

• Encounter45Pat01: Pat01 Encounter on 2018-07-21

• Group01: Risk Adjustment Patient Group, (Patient01: Eve Everywoman)

• Group02: Risk Adjustment Patient Group, (Patient02: Adam Everyman, Patient03: Nelda Nuclear)

• Measure01: Risk Adjustment Model CMS-HCC V24
• Measure02: Risk Adjustment Model CMS-HCC V21

• Measure03: Risk Adjustment Model CMS-RxHCC V05

• MeasureReport01: Risk Adjustment Coding Gap Report, RA Model CMS-HCC V24 (Patient01: Eve Everywoman)
• MeasureReport02: Risk Adjustment Coding Gap Report, RA Model CMS-RxHCC V5 (Patient01: Eve Everywoman)
• MeasureReport03: Risk Adjustment Coding Gap Report, RA Model CMS-HCC V24 (Patient02: Adam Everyman)
• MeasureReport04: Risk Adjustment Coding Gap Report, RA Model CMS-HCC V21 (Patient03: Nelda Nuclear)
• MeasureReport05: Risk Adjustment Coding Gap Report, RA Model CMS-RxHCC V5 (Patient03: Nelda Nuclear)

• MeasureReport06: Risk Adjustment Coding Gap Report, RA Model CMS-RxHCC V5 (Patient02: Adam Everyman)

• Observation01Pat03: Pat03 Creatinine on 20210728
• Observation02Pat03: Pat03 PHQ9 on 20190823

• Observation21Pat01: Pat01 Trypsin (Mass/volume) in Serum or Plasma from 20170617

• Organization01: Payer Organization ABC Payer

• Organization01Pat01: Community Urgent Care
• Organization02Pat02: GHH Outpatient Clinic

• Organization01pat03: Community HealthCenter

• Parameters01: Report return, subject Eve Everywoman

• Patient01: Eve Everywoman
• Patient02: Adam Everyman

• Patient03: Nelda Nuclear

• Practitioner01: Harold Hippocrates
• Practitioner02: Patrick Pump
• Practitioner03: Otto Osler